macitentan

Poland

Drugs containing this active substance

  • MACITENTAN OLPHA

    The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults and in children under 18 years of age weighing at least 40 kg. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers blood pressure, and reduces disease symptoms.

    Form: tablets, film-coated

    Active substance Dosage
    macitentan 10 mg

    ATC: C02KX04

    Manufacturer: Genepharm S.A. Olpha AS

  • MACITENTAN ONKOGEN

    This medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH). It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers blood pressure, and reduces disease symptoms such as fatigue, dizziness, and shortness of breath.

    Form: tablets, film-coated

    Active substance Dosage
    macitentan 10 mg

    ATC: C02KX04

    Manufacturer: Tecnimede-Sociedade Técnico-Medicinal S.A.

  • MACITENTAN SANDOZ

    This medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults and in children over 18 years of age weighing at least 40 kg. It works by dilating the pulmonary arteries, which makes it easier for the heart to pump blood and lowers blood pressure.

    Form: tablets, film-coated

    Active substance Dosage
    macitentan 10 mg

    ATC: C02KX04

    Manufacturer: Salutas Pharma GmbH

  • MACITENTAN STADA

    This medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults and in children over 18 years of age weighing at least 40 kg. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers blood pressure, and reduces disease symptoms such as fatigue or shortness of breath.

    Form: tablets, film-coated

    Active substance Dosage
    macitentan 10 mg

    ATC: C02KX04

    Manufacturer: Centrafarm Services B.V.

  • MACITENTAN TEVA

    The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults and in children over 18 years of age weighing at least 40 kg, who are in WHO functional class II to III. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood and reduces the symptoms of the disease.

    Form: tablets, film-coated

    Active substance Dosage
    macitentan 10 mg

    ATC: C02KX04

    Manufacturer: Balkanpharma-Dupnitsa AD

  • MACITENTAN TZF

    The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults and in children weighing more than 40 kg. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers pressure, and reduces disease symptoms.

    Form: tablets, film-coated

    Active substance Dosage
    macitentan 10 mg

    ATC: C02KX04

    Manufacturer: Coripharma ehf.